Methenamine Hippurate Tablet
Product Images NDC 65862-782

1 FDA label image from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 65862-782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (1 g (100 Tablets Bottle))

Package Label.principal Display Panel (1 g (100 Tablets Bottle))
Label for Methenamine Hippurate Tablets USP 1 g oral tablets by Aurobindo Pharma Limited. The label includes dosage strength (1 g), package count (100 tablets), distributor information for Aurobindo Pharma USA, and storage instructions at controlled room temperature (20° to 25°C). It also contains warnings to keep out of reach of children and pharmacist dispensing instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.